Glycopyrrolate Market Definition
Glycopyrrolate is an anticholinergic that helps to control conditions such as peptic ulcers that involve excessive stomach acid production. Glycopyrrolate occurs as a white, odorless crystalline powder. It is soluble in water and alcohol and practically insoluble in chloroform and ether. The injectable form of glycopyrrolate is used to reduce saliva, nasal, lung and stomach secretions and to help control heart rate during surgery.
The market study is broken down, by Application (Hospitals and Clinics) and major geographies with country level splits.
The Market For Glycopyrrolate is Fragmented With the Presence Of Many Players. Leading Players Can Adopt Strategies Like A Merger, Acquisition, Expansion, New Product Launch, In Order To Gain Share Within the Market. Owing To Booming Industrialization & Urbanization, There Are Growing Prospects For The New Players To Enter The Market. Research Analyst at AMA estimates that Italy Players will contribute to the maximum growth of Global Glycopyrrolate market throughout the predicted period.
Infa Group S.P.A. (Italy), Suven Life Sciences, Ltd. (India), Sharon Bio-Medicine Ltd. (India), Tai Heng Industry Co., Ltd (China), Stellar Chemical Laboratories Pvt. Ltd. (India), Inke S.A. (Italy), A.M.S.A SPA (Italy), C.H. Boehringer Sohn AG & Ko. KG (Germany), Cerbios-Pharma SA (Switzerland), Dipharma Francis S.r.l (Italy), Harman Finochem (India) and Hikma Pharmaceuticals (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are AKASHAT PHARMA Pvt. Ltd. (India), Aurobindo Pharma Limited (India), Khandelwal Laboratories Pvt. Ltd. (India), Hovione (Portugal), Tooba Pharma Pvt. Ltd. (India) and HARMA RIVATE LT.
AdvanceMarketAnalytics has segmented the market of Global Glycopyrrolate market by Type, Application and Region.
On the basis of geography, the market of Glycopyrrolate has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Form, the sub-segment i.e. Tablet will boost the Glycopyrrolate market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sales Channel, the sub-segment i.e. Offline (Pharma Stores, Medical Outlets) will boost the Glycopyrrolate market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
In 29 April 2019, Fresenius Kabi , A Pharmaceutical Company Launched Glycopyrrolate Injection, USP Simplist Prefilled Syringes In 0.2 Mg Per 1 Ml And 0.4 Mg Per 2 Ml Single Dose In Simplist Ready-To-Administer Prefilled Syringes. and In 1st November 2019, Indoco Remedies Ltd., an Indian Based Pharmaceutical Company Got United States Food & Drug Administration (USFDA) Approval for Glycopyrrolate Abbreviated New Drug Application (ANDA)
- The Use Of Glycopyrrolate To Cure Excessive Drooling In Children Is Increasing
- The Demand for Curing Disease Such As Peptic Ulcers Leads To the Growth in Glycopyrrolate
- The Growing Use of Glycopyrrolate by Inhaling Used To Treat Disease Such As Chronic Obstructive Pulmonary Disease
- Glycopyrrolate Reduces the Body's Ability to Sweat and May Cause Hyperthermia and Heat Stroke In Hot Environment
- Glycopyrrolate May Cause Some Serious Causes Such As Diarrhea, Rash and Hives
Key Target AudienceGlycopyrrolate Manufacturers, Raw Material Suppliers, New Entrants/Investors, Dealers, Suppliers, Traders, and Distributors, Government Regulatory and Research Organizations and End-Use Industry
About ApproachThe research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase